{"entity":{"type":"insider","cik":"0001724310","url":"/insider/0001724310","json_url":"/insider/0001724310.json","name":"Watts Ryan J.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":122,"n_filings":51,"first":"2018-08-31","last":"2026-01-08","span_basis":"filed_date"},"name_variants":[{"name":"Watts Ryan J.","source":"filing","n_filings":51,"first_seen":"2018-08-31","last_seen":"2026-01-08"}],"transactions":[{"id":5923077,"accession":"0001724310-26-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001724310-26-000004","line_url":"/filing/0001724310-26-000004#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724310","owner_name":"Watts Ryan J.","owner_display_name":"Watts Ryan J.","owner_url":"/insider/0001724310","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35198.0,"shares_display":"35,198","price_per_share":16.5,"price_display":"16.50","price_state":"stated","total_value":580767.0,"total_display":"580,767.00","total_whole":"580,767","shares_owned_after":296833.0,"shares_owned_after_display":"296,833","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-06","filed_date":"2026-01-08","scope":"insider"},{"id":4075914,"accession":"0001714899-25-000149","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001714899-25-000149","line_url":"/filing/0001714899-25-000149#line-3","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724310","owner_name":"Watts Ryan J.","owner_display_name":"Watts Ryan J.","owner_url":"/insider/0001724310","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":495282.0,"shares_display":"495,282","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":7429230.0,"total_display":"7,429,230.00","total_whole":"7,429,230","shares_owned_after":253071.0,"shares_owned_after_display":"253,071","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-09","filed_date":"2025-07-11","scope":"insider"},{"id":4999770,"accession":"0001714899-25-000049","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001714899-25-000049","line_url":"/filing/0001714899-25-000049#line-2","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724310","owner_name":"Watts Ryan J.","owner_display_name":"Watts Ryan J.","owner_url":"/insider/0001724310","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7650.0,"shares_display":"7,650","price_per_share":20.81,"price_display":"20.81","price_state":"stated","total_value":159196.5,"total_display":"159,196.50","total_whole":"159,197","shares_owned_after":253071.0,"shares_owned_after_display":"253,071","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-07","filed_date":"2025-01-08","scope":"insider"},{"id":4999764,"accession":"0001714899-25-000049","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-25-000049","line_url":"/filing/0001714899-25-000049#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724310","owner_name":"Watts Ryan J.","owner_display_name":"Watts Ryan J.","owner_url":"/insider/0001724310","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29266.0,"shares_display":"29,266","price_per_share":20.22,"price_display":"20.22","price_state":"stated","total_value":591758.52,"total_display":"591,758.52","total_whole":"591,759","shares_owned_after":260721.0,"shares_owned_after_display":"260,721","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-06","filed_date":"2025-01-08","scope":"insider"},{"id":2125113,"accession":"0001714899-24-000206","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001714899-24-000206","line_url":"/filing/0001714899-24-000206#line-2","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724310","owner_name":"Watts Ryan J.","owner_display_name":"Watts Ryan J.","owner_url":"/insider/0001724310","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":27.69,"price_display":"27.69","price_state":"stated","total_value":1107600.0,"total_display":"1,107,600.00","total_whole":"1,107,600","shares_owned_after":235807.0,"shares_owned_after_display":"235,807","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-18","filed_date":"2024-10-22","scope":"insider"},{"id":2065453,"accession":"0001714899-24-000197","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-24-000197","line_url":"/filing/0001714899-24-000197#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724310","owner_name":"Watts Ryan J.","owner_display_name":"Watts Ryan J.","owner_url":"/insider/0001724310","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2260.0,"shares_display":"2,260","price_per_share":23.79,"price_display":"23.79","price_state":"stated","total_value":53765.4,"total_display":"53,765.40","total_whole":"53,765","shares_owned_after":235807.0,"shares_owned_after_display":"235,807","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-20","filed_date":"2024-08-22","scope":"insider"},{"id":2327832,"accession":"0001714899-24-000061","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-24-000061","line_url":"/filing/0001714899-24-000061#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724310","owner_name":"Watts Ryan J.","owner_display_name":"Watts Ryan J.","owner_url":"/insider/0001724310","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9589.0,"shares_display":"9,589","price_per_share":17.29,"price_display":"17.29","price_state":"stated","total_value":165793.81,"total_display":"165,793.81","total_whole":"165,794","shares_owned_after":238067.0,"shares_owned_after_display":"238,067","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-13","filed_date":"2024-02-15","scope":"insider"},{"id":2165417,"accession":"0001714899-24-000039","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-24-000039","line_url":"/filing/0001714899-24-000039#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724310","owner_name":"Watts Ryan J.","owner_display_name":"Watts Ryan J.","owner_url":"/insider/0001724310","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7818.0,"shares_display":"7,818","price_per_share":19.78,"price_display":"19.78","price_state":"stated","total_value":154640.04,"total_display":"154,640.04","total_whole":"154,640","shares_owned_after":2268363.0,"shares_owned_after_display":"2,268,363","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-09","filed_date":"2024-01-11","scope":"insider"},{"id":2195747,"accession":"0001714899-24-000035","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-24-000035","line_url":"/filing/0001714899-24-000035#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724310","owner_name":"Watts Ryan J.","owner_display_name":"Watts Ryan J.","owner_url":"/insider/0001724310","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17483.0,"shares_display":"17,483","price_per_share":19.43,"price_display":"19.43","price_state":"stated","total_value":339694.69,"total_display":"339,694.69","total_whole":"339,695","shares_owned_after":2276181.0,"shares_owned_after_display":"2,276,181","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-05","filed_date":"2024-01-09","scope":"insider"},{"id":8757228,"accession":"0001714899-23-000133","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-23-000133","line_url":"/filing/0001714899-23-000133#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724310","owner_name":"Watts Ryan J.","owner_display_name":"Watts Ryan J.","owner_url":"/insider/0001724310","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2309.0,"shares_display":"2,309","price_per_share":22.59,"price_display":"22.59","price_state":"stated","total_value":52160.31,"total_display":"52,160.31","total_whole":"52,160","shares_owned_after":2242604.0,"shares_owned_after_display":"2,242,604","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-21","filed_date":"2023-08-23","scope":"insider"},{"id":8026285,"accession":"0001714899-23-000123","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001714899-23-000123","line_url":"/filing/0001714899-23-000123#line-2","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724310","owner_name":"Watts Ryan J.","owner_display_name":"Watts Ryan J.","owner_url":"/insider/0001724310","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2526.0,"shares_display":"2,526","price_per_share":25.03,"price_display":"25.03","price_state":"stated","total_value":63225.78,"total_display":"63,225.78","total_whole":"63,226","shares_owned_after":2239913.0,"shares_owned_after_display":"2,239,913","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-10","filed_date":"2023-08-14","scope":"insider"},{"id":7911020,"accession":"0001714899-23-000105","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001714899-23-000105","line_url":"/filing/0001714899-23-000105#line-2","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724310","owner_name":"Watts Ryan J.","owner_display_name":"Watts Ryan J.","owner_url":"/insider/0001724310","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":31.4,"price_display":"31.40","price_state":"stated","total_value":1570000.0,"total_display":"1,570,000.00","total_whole":"1,570,000","shares_owned_after":2239913.0,"shares_owned_after_display":"2,239,913","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-16","filed_date":"2023-06-20","scope":"insider"},{"id":8594494,"accession":"0001714899-23-000066","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001714899-23-000066","line_url":"/filing/0001714899-23-000066#line-4","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724310","owner_name":"Watts Ryan J.","owner_display_name":"Watts Ryan J.","owner_url":"/insider/0001724310","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24800.0,"shares_display":"24,800","price_per_share":25.15,"price_display":"25.15","price_state":"stated","total_value":623720.0,"total_display":"623,720.00","total_whole":"623,720","shares_owned_after":2239913.0,"shares_owned_after_display":"2,239,913","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-04-21","filed_date":"2023-04-24","scope":"insider"},{"id":8594487,"accession":"0001714899-23-000066","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001714899-23-000066","line_url":"/filing/0001714899-23-000066#line-2","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724310","owner_name":"Watts Ryan J.","owner_display_name":"Watts Ryan J.","owner_url":"/insider/0001724310","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":5000.0,"total_display":"5,000.00","total_whole":"5,000","shares_owned_after":2239913.0,"shares_owned_after_display":"2,239,913","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-04-20","filed_date":"2023-04-24","scope":"insider"},{"id":8344876,"accession":"0001714899-23-000029","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001714899-23-000029","line_url":"/filing/0001714899-23-000029","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724310","owner_name":"Watts Ryan J.","owner_display_name":"Watts Ryan J.","owner_url":"/insider/0001724310","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33815.0,"shares_display":"33,815","price_per_share":30.08260683128789,"price_display":"30.08","price_state":"stated","total_value":1017243.35,"total_display":"1,017,243.35","total_whole":"1,017,243","shares_owned_after":2239913.0,"shares_owned_after_display":"2,239,913","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-13","filed_date":"2023-02-15","scope":"insider","n_lines":2},{"id":8757207,"accession":"0001714899-23-000023","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001714899-23-000023","line_url":"/filing/0001714899-23-000023#line-3","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724310","owner_name":"Watts Ryan J.","owner_display_name":"Watts Ryan J.","owner_url":"/insider/0001724310","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":29.1,"price_display":"29.10","price_state":"stated","total_value":727500.0,"total_display":"727,500.00","total_whole":"727,500","shares_owned_after":2229031.0,"shares_owned_after_display":"2,229,031","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-10","filed_date":"2023-02-13","scope":"insider"},{"id":8757200,"accession":"0001714899-23-000023","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-23-000023","line_url":"/filing/0001714899-23-000023#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724310","owner_name":"Watts Ryan J.","owner_display_name":"Watts Ryan J.","owner_url":"/insider/0001724310","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3433.0,"shares_display":"3,433","price_per_share":30.59,"price_display":"30.59","price_state":"stated","total_value":105015.47,"total_display":"105,015.47","total_whole":"105,015","shares_owned_after":2229031.0,"shares_owned_after_display":"2,229,031","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-09","filed_date":"2023-02-13","scope":"insider"},{"id":8757197,"accession":"0001714899-23-000013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-23-000013","line_url":"/filing/0001714899-23-000013#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724310","owner_name":"Watts Ryan J.","owner_display_name":"Watts Ryan J.","owner_url":"/insider/0001724310","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4800.0,"shares_display":"4,800","price_per_share":28.44,"price_display":"28.44","price_state":"stated","total_value":136512.0,"total_display":"136,512.00","total_whole":"136,512","shares_owned_after":2223664.0,"shares_owned_after_display":"2,223,664","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-05","filed_date":"2023-01-09","scope":"insider"},{"id":8150766,"accession":"0001209191-23-002179","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-002179","line_url":"/filing/0001209191-23-002179#line-2","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724310","owner_name":"Watts Ryan J.","owner_display_name":"Watts Ryan J.","owner_url":"/insider/0001724310","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5029.0,"shares_display":"5,029","price_per_share":28.73,"price_display":"28.73","price_state":"stated","total_value":144483.17,"total_display":"144,483.17","total_whole":"144,483","shares_owned_after":2213464.0,"shares_owned_after_display":"2,213,464","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-04","filed_date":"2023-01-05","scope":"insider"},{"id":6525701,"accession":"0001714899-22-000129","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-22-000129","line_url":"/filing/0001714899-22-000129#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724310","owner_name":"Watts Ryan J.","owner_display_name":"Watts Ryan J.","owner_url":"/insider/0001724310","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2404.0,"shares_display":"2,404","price_per_share":33.22,"price_display":"33.22","price_state":"stated","total_value":79860.88,"total_display":"79,860.88","total_whole":"79,861","shares_owned_after":2202993.0,"shares_owned_after_display":"2,202,993","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-08-19","filed_date":"2022-08-23","scope":"insider"},{"id":6311995,"accession":"0001714899-22-000042","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-22-000042","line_url":"/filing/0001714899-22-000042#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724310","owner_name":"Watts Ryan J.","owner_display_name":"Watts Ryan J.","owner_url":"/insider/0001724310","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9491.0,"shares_display":"9,491","price_per_share":34.72,"price_display":"34.72","price_state":"stated","total_value":329527.52,"total_display":"329,527.52","total_whole":"329,528","shares_owned_after":2129648.0,"shares_owned_after_display":"2,129,648","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-11","filed_date":"2022-02-15","scope":"insider"},{"id":6764378,"accession":"0001714899-22-000035","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-22-000035","line_url":"/filing/0001714899-22-000035#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724310","owner_name":"Watts Ryan J.","owner_display_name":"Watts Ryan J.","owner_url":"/insider/0001724310","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2719.0,"shares_display":"2,719","price_per_share":37.5519,"price_display":"37.55","price_state":"stated","total_value":102103.6161,"total_display":"102,103.62","total_whole":"102,104","shares_owned_after":2119442.0,"shares_owned_after_display":"2,119,442","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-09","filed_date":"2022-02-11","scope":"insider"},{"id":6335383,"accession":"0001714899-22-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-22-000008","line_url":"/filing/0001714899-22-000008#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724310","owner_name":"Watts Ryan J.","owner_display_name":"Watts Ryan J.","owner_url":"/insider/0001724310","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5007.0,"shares_display":"5,007","price_per_share":44.78,"price_display":"44.78","price_state":"stated","total_value":224213.46,"total_display":"224,213.46","total_whole":"224,213","shares_owned_after":2113361.0,"shares_owned_after_display":"2,113,361","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-05","filed_date":"2022-01-07","scope":"insider"},{"id":4740799,"accession":"0001714899-21-000114","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001714899-21-000114","line_url":"/filing/0001714899-21-000114","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724310","owner_name":"Watts Ryan J.","owner_display_name":"Watts Ryan J.","owner_url":"/insider/0001724310","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18333.0,"shares_display":"18,333","price_per_share":44.92339442535319,"price_display":"44.92","price_state":"stated","total_value":823580.59,"total_display":"823,580.59","total_whole":"823,581","shares_owned_after":2104173.0,"shares_owned_after_display":"2,104,173","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-01","filed_date":"2021-12-03","scope":"insider","n_lines":3},{"id":4491888,"accession":"0001714899-21-000097","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001714899-21-000097","line_url":"/filing/0001714899-21-000097","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724310","owner_name":"Watts Ryan J.","owner_display_name":"Watts Ryan J.","owner_url":"/insider/0001724310","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18333.0,"shares_display":"18,333","price_per_share":49.7559793814433,"price_display":"49.76","price_state":"stated","total_value":912176.37,"total_display":"912,176.37","total_whole":"912,176","shares_owned_after":2121701.0,"shares_owned_after_display":"2,121,701","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-01","filed_date":"2021-11-03","scope":"insider","n_lines":2},{"id":5013580,"accession":"0001714899-21-000093","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001714899-21-000093","line_url":"/filing/0001714899-21-000093","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724310","owner_name":"Watts Ryan J.","owner_display_name":"Watts Ryan J.","owner_url":"/insider/0001724310","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18333.0,"shares_display":"18,333","price_per_share":50.37637757050128,"price_display":"50.38","price_state":"stated","total_value":923550.13,"total_display":"923,550.13","total_whole":"923,550","shares_owned_after":2144281.0,"shares_owned_after_display":"2,144,281","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-01","filed_date":"2021-10-05","scope":"insider","n_lines":3},{"id":5231701,"accession":"0001714899-21-000089","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001714899-21-000089","line_url":"/filing/0001714899-21-000089","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724310","owner_name":"Watts Ryan J.","owner_display_name":"Watts Ryan J.","owner_url":"/insider/0001724310","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18333.0,"shares_display":"18,333","price_per_share":54.65617793050783,"price_display":"54.66","price_state":"stated","total_value":1002011.71,"total_display":"1,002,011.71","total_whole":"1,002,012","shares_owned_after":2158367.0,"shares_owned_after_display":"2,158,367","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-01","filed_date":"2021-09-03","scope":"insider","n_lines":2},{"id":4399508,"accession":"0001714899-21-000085","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001714899-21-000085","line_url":"/filing/0001714899-21-000085","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724310","owner_name":"Watts Ryan J.","owner_display_name":"Watts Ryan J.","owner_url":"/insider/0001724310","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2376.0,"shares_display":"2,376","price_per_share":49.56623737373737,"price_display":"49.57","price_state":"stated","total_value":117769.38,"total_display":"117,769.38","total_whole":"117,769","shares_owned_after":2177450.0,"shares_owned_after_display":"2,177,450","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-19","filed_date":"2021-08-23","scope":"insider","n_lines":2},{"id":5506212,"accession":"0001714899-21-000080","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001714899-21-000080","line_url":"/filing/0001714899-21-000080","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724310","owner_name":"Watts Ryan J.","owner_display_name":"Watts Ryan J.","owner_url":"/insider/0001724310","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18333.0,"shares_display":"18,333","price_per_share":51.40877106856488,"price_display":"51.41","price_state":"stated","total_value":942477.0,"total_display":"942,477.00","total_whole":"942,477","shares_owned_after":2174076.0,"shares_owned_after_display":"2,174,076","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-02","filed_date":"2021-08-04","scope":"insider","n_lines":2},{"id":4274958,"accession":"0001209191-21-045422","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-045422","line_url":"/filing/0001209191-21-045422","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724310","owner_name":"Watts Ryan J.","owner_display_name":"Watts Ryan J.","owner_url":"/insider/0001724310","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18333.0,"shares_display":"18,333","price_per_share":77.2541378388698,"price_display":"77.25","price_state":"stated","total_value":1416300.109,"total_display":"1,416,300.11","total_whole":"1,416,300","shares_owned_after":2194868.0,"shares_owned_after_display":"2,194,868","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-01","filed_date":"2021-07-06","scope":"insider","n_lines":3},{"id":4093700,"accession":"0001209191-21-037981","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-037981","line_url":"/filing/0001209191-21-037981","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724310","owner_name":"Watts Ryan J.","owner_display_name":"Watts Ryan J.","owner_url":"/insider/0001724310","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18333.0,"shares_display":"18,333","price_per_share":61.40011040200731,"price_display":"61.40","price_state":"stated","total_value":1125648.224,"total_display":"1,125,648.22","total_whole":"1,125,648","shares_owned_after":2215948.0,"shares_owned_after_display":"2,215,948","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-01","filed_date":"2021-06-03","scope":"insider","n_lines":4},{"id":5490753,"accession":"0001209191-21-030300","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-030300","line_url":"/filing/0001209191-21-030300","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724310","owner_name":"Watts Ryan J.","owner_display_name":"Watts Ryan J.","owner_url":"/insider/0001724310","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18333.0,"shares_display":"18,333","price_per_share":58.6429793814433,"price_display":"58.64","price_state":"stated","total_value":1075101.741,"total_display":"1,075,101.74","total_whole":"1,075,102","shares_owned_after":2233411.0,"shares_owned_after_display":"2,233,411","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-03","filed_date":"2021-05-05","scope":"insider","n_lines":3},{"id":4891629,"accession":"0001209191-21-025115","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-025115","line_url":"/filing/0001209191-21-025115#line-4","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724310","owner_name":"Watts Ryan J.","owner_display_name":"Watts Ryan J.","owner_url":"/insider/0001724310","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8516.0,"shares_display":"8,516","price_per_share":56.876,"price_display":"56.88","price_state":"stated","total_value":484356.016,"total_display":"484,356.02","total_whole":"484,356","shares_owned_after":2251994.0,"shares_owned_after_display":"2,251,994","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-04-01","filed_date":"2021-04-05","scope":"insider"},{"id":4891627,"accession":"0001209191-21-025115","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-025115","line_url":"/filing/0001209191-21-025115#line-3","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724310","owner_name":"Watts Ryan J.","owner_display_name":"Watts Ryan J.","owner_url":"/insider/0001724310","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5232.0,"shares_display":"5,232","price_per_share":55.521,"price_display":"55.52","price_state":"stated","total_value":290485.872,"total_display":"290,485.87","total_whole":"290,486","shares_owned_after":2260510.0,"shares_owned_after_display":"2,260,510","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-04-01","filed_date":"2021-04-05","scope":"insider"}],"collapsed":true,"next_cursor":"2021-04-01|4891627","ledger_fault":false,"count":{"value":122,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":122,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":122},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001714899","name":"Denali Therapeutics Inc.","url":"/issuer/0001714899","role":"Director, Officer (President and CEO)","n_filings":51,"first_seen":"2018-08-31","last_seen":"2026-01-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001724310","retrieved_at":"2026-08-22T22:46:44+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}